Related references
Note: Only part of the references are listed.The IKKβ-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis
Li Gu et al.
HEPATOLOGY (2021)
PPARγ Coactivator-1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ-Dependent WNT/β-Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis
Qiaozhu Zuo et al.
HEPATOLOGY (2021)
Operative ubiquitin-specific protease 22 deubiquitination confers a more invasive phenotype to cholangiocarcinoma
Yu Tian et al.
CELL DEATH & DISEASE (2021)
An integrative pan-cancer analysis of biological and clinical impacts underlying ubiquitin-specific-processing proteases
Di Chen et al.
ONCOGENE (2020)
Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression
Kyung Hee Noh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
James S. Lally et al.
CELL METABOLISM (2019)
Aberrant lipid metabolism as a therapeutic target in liver cancer
Evans D. Pope et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Metabolic Profiling Reveals Biochemical Pathways and Potential Biomarkers of Spinocerebellar Ataxia 3
Zhi-hua Yang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity
Xing Huang et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPAR? for proteasomal degradation
Hao Dou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
A Multidimensional Characterization of E3 Ubiquitin Ligase and Substrate Interaction Network
Di Chen et al.
ISCIENCE (2019)
Development of a High Coverage Pseudotargeted Lipidomics Method Based on Ultra-High Performance Liquid Chromatography-Mass Spectrometry
Qiuhui Xuan et al.
ANALYTICAL CHEMISTRY (2018)
Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People
Yuanjie Pang et al.
HEPATOLOGY (2018)
An Hsp20-FBXO4 Axis Regulates Adipocyte Function through Modulating PPARγ Ubiquitination
Jiangtong Peng et al.
CELL REPORTS (2018)
Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells
Victoria J. Gennaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration
Tae Hyun Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities
Serena De Matteis et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Proteome-wide analysis of USP14 substrates revealed its role in hepatosteatosis via stabilization of FASN
Bin Liu et al.
NATURE COMMUNICATIONS (2018)
Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription
Cecilia Patitucci et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
Ubiquitin Specific Peptidase 22 Regulates Histone H2B Mono-Ubiquitination and Exhibits Both Oncogenic and Tumor Suppressor Roles in Cancer
Lucile M-P. Jeusset et al.
CANCERS (2017)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Acetyl-Coenzyme A Carboxylase Alpha Promotion of Glucose-Mediated Fatty Acid Synthesis Enhances Survival of Hepatocellular Carcinoma in Mice and Patients
Ming-Da Wang et al.
HEPATOLOGY (2016)
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
Lei Li et al.
JOURNAL OF HEPATOLOGY (2016)
Amplification of USP13 drives ovarian cancer metabolism
Cecil Han et al.
NATURE COMMUNICATIONS (2016)
The multifaceted roles of fatty acid synthesis in cancer
Florian Roehrig et al.
NATURE REVIEWS CANCER (2016)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1
Zhenghong Lin et al.
CELL DISCOVERY (2015)
Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation
J-H Kim et al.
CELL DEATH AND DIFFERENTIATION (2014)
PPARγ and the global map of adipogenesis and beyond
Martina I. Lefterova et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
Qiang Huang et al.
CANCER RESEARCH (2013)
Cellular Fatty Acid Metabolism and Cancer
Erin Currie et al.
CELL METABOLISM (2013)
Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated With Progression of Hepatocellular Carcinoma and Patient Outcomes
Anuradha Budhu et al.
GASTROENTEROLOGY (2013)
Acetylation Stabilizes ATP-Citrate Lyase to Promote Lipid Biosynthesis and Tumor Growth
Ruiting Lin et al.
MOLECULAR CELL (2013)
Proteasome deubiquitinases as novel targets for cancer therapy
Padraig D'Arcy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Gyoergy Baffy et al.
JOURNAL OF HEPATOLOGY (2012)
USP22 Antagonizes p53 Transcriptional Activation by Deubiquitinating Sirt1 to Suppress Cell Apoptosis and Is Required for Mouse Embryonic Development
Zhenghong Lin et al.
MOLECULAR CELL (2012)
PPARγ contributes to PKM2 and HK2 expression in fatty liver
Ganna Panasyuk et al.
NATURE COMMUNICATIONS (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
Diego F. Calvisi et al.
GASTROENTEROLOGY (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
DUBs and cancer The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors
Sajjad Hussain et al.
CELL CYCLE (2009)
A TFTC/STAGA module mediates histone H2A and H2B deubiquitination, coactivates nuclear receptors, and counteracts heterochromatin silencing
Yue Zhao et al.
MOLECULAR CELL (2008)
Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARγ
Kock Hwan Kim et al.
GASTROENTEROLOGY (2007)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Transcriptional regulation of metabolism
B Desvergne et al.
PHYSIOLOGICAL REVIEWS (2006)
A genomic and functional inventory of deubiquitinating enzymes
SMB Nijman et al.
CELL (2005)
Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes
K Matsusue et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Share Paper
